Bayer and Hologic, Inc., today announced an international partnership to deliver contrast-enhanced-mammography (CEM) solutions to improve the detection of breast cancer in multiple countries across Canada, the European and Asia Pacific regions.
CEM is an innovative highly sensitive and low-cost breast imaging modality which combines digital mammography with the administration of a contrast agent to support breast cancer diagnosis and guide treatment decisions.
Leading WiFi provider WiFi SPARK is rebranding its healthcare arm as SPARK Technology Services Limited. The new identity marks the completion of the integration of the former Hospedia bedside unit business and a new vision for the NHS, based on patient engagement and application services.
The Danish eHealth platform, sundhed.dk, has faced a substantial surge in requests from Danish citizens
and has swiftly expanded its support and effectively adapt to the ongoing changes in queries due to the ongoing changes within the Health Industry. To accommodate these changes, sundhed.dk uses the Chatbot
from SupWiz to solve urgent needs for support and provides a nice citizen experience.
Mahana Therapeutics, a leading provider of prescription digital therapeutics, announced today that the company has entered into a multi-million-dollar distribution and marketing partnership with the Consumer Health division of Bayer to commercialize digital therapeutics. Earlier this year, Bayer announced the launch of a new business unit focused on delivering new digitally enabled precision health products to market.
Health technology trade association ABHI has announced that specialist marketing, PR and communications agency Highland Marketing has joined its membership.
Highland Marketing has worked with technology providers throughout the health and care sector for more than two decades, helping to bring innovations to market and raise awareness of the positive impact technologies enable for clinical teams and patients.
Frimley Health NHS Foundation Trust and Qure.ai have announced the early results of a pilot study using an innovative radiology AI solution to read and differentiate between normal and abnormal chest X-rays (CXRs).
qXR, a CE class IIb MDR cleared solution developed by Qure, was deployed with the hypothesis to categorise normal x-rays - approximately 40% of the caseload from GP and outpatient requests - and augment overall reporting efficiency.